TrialPsychopharmacology2023
Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results.
Alan Breier et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this paperpooled itcites it